Monitoring multiple sclerosis treatment with plasma biomarkers: NFL, GFAP, UCH-L1, and Tau

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2020
This article has no abstract
Epistemonikos ID: 1a73c3b42233783a47a6e4870bcb75082cf82084
First added on: Apr 30, 2026